Form 8-K - Current report:
SEC Accession No. 0001104659-21-005360
Filing Date
2021-01-19
Accepted
2021-01-19 16:37:26
Documents
13
Period of Report
2021-01-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213310d3_8k.htm   iXBRL 8-K 29736
2 EXHIBIT 99.1 tm213310d3_ex99-1.htm EX-99.1 8411
  Complete submission text file 0001104659-21-005360.txt   215440

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA edit-20210119.xsd EX-101.SCH 3205
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE edit-20210119_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edit-20210119_pre.xml EX-101.PRE 22723
6 EXTRACTED XBRL INSTANCE DOCUMENT tm213310d3_8k_htm.xml XML 3490
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 21535968
SIC: 2836 Biological Products, (No Diagnostic Substances)